MedicQuant

Employees
1–10
Founded
2019
Business Model
B2B

About

MedicQuant is a spin-out from the Gothelf Lab at iNANO, Aarhus University, Denmark, built on more than 11 years of research. Its patent-pending platform uses DNA nanotechnology to measure small-molecule drug concentrations in whole blood at the point of care, with laboratory-comparable accuracy in about 10 minutes. Assays are being developed first for anticoagulants so clinicians can make faster decisions in acute stroke care, and the same platform has shown proof of concept for antibiotics, anticancer drugs, and antirheumatic drugs. A disposable flow-front immunoassay cartridge processes whole blood with minimal handling and has been rated easy or very easy to use in usability studies.

Summary

MedicQuant is a Biotech company, founded in 2019.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MedicQuant on Indexed.vc
<a href="https://indexed.vc/companies/medicquant"><img src="https://indexed.vc/api/badge/company/medicquant" alt="MedicQuant on Indexed.vc" width="260" height="76" /></a>